AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 204 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 16.41 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,673,530 | -6.3% | 36,389 | +17.0% | 0.91% | +14.8% |
| Q2 2023 | $1,786,685 | +645.7% | 31,089 | +386.6% | 0.80% | +745.7% |
| Q1 2023 | $239,588 | -75.7% | 6,389 | -81.8% | 0.09% | -71.5% |
| Q4 2022 | $984,987 | -67.0% | 35,153 | -66.9% | 0.33% | -64.1% |
| Q3 2022 | $2,984,000 | -29.4% | 106,200 | -12.6% | 0.92% | +8.0% |
| Q2 2022 | $4,227,000 | +278.8% | 121,500 | +290.7% | 0.85% | +158.2% |
| Q1 2022 | $1,116,000 | – | 31,100 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LAM GROUP, INC. | 130,250 | $3,649,605 | 3.75% |
| SHAKER INVESTMENTS LLC/OH | 81,287 | $2,277,662 | 1.41% |
| Mesirow Institutional Investment Management, Inc. | 374,414 | $10,491,080 | 1.38% |
| OBERWEIS ASSET MANAGEMENT INC/ | 134,000 | $3,754,680 | 0.80% |
| Portolan Capital Management | 270,791 | $7,587,564 | 0.75% |
| Hillsdale Investment Management Inc. | 172,238 | $4,826,109 | 0.41% |
| Capital Impact Advisors, LLC | 14,669 | $411,025 | 0.40% |
| Watershed Asset Management, L.L.C. | 9,555 | $267,731 | 0.34% |
| Quantedge Capital Pte Ltd | 35,153 | $984,987 | 0.33% |
| FEDERATED HERMES, INC. | 3,284,217 | $92,023,760 | 0.25% |